Patents by Inventor Paul Sudhakar

Paul Sudhakar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20240082259
    Abstract: The present invention provides for an oral liquid suspension that includes quetiapine or a pharmaceutically acceptable salt thereof. Also provided is a method for orally delivering quetiapine fumarate to a subject (e.g., for treating a mental disorder in a subject, such as schizophrenia, bipolar mania, and/or bipolar depression). The method includes orally administering to the subject an oral liquid suspension described herein.
    Type: Application
    Filed: November 13, 2023
    Publication date: March 14, 2024
    Inventors: Paul Sudhakar, Scott Boyer
  • Topiramate oral liquid suspension and use thereof
    Patent number: 11872309
    Abstract: Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: January 16, 2024
    Inventors: Paul Sudhakar, Scott Boyer
  • TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20230414503
    Abstract: Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
    Type: Application
    Filed: September 7, 2023
    Publication date: December 28, 2023
    Inventors: Paul Sudhakar, Scott Boyer
  • Quetiapine oral liquid suspension and use thereof
    Patent number: 11813269
    Abstract: The present invention provides for an oral liquid suspension that includes quetiapine or a pharmaceutically acceptable salt thereof. Also provided is a method for orally delivering quetiapine fumarate to a subject (e.g., for treating a mental disorder in a subject, such as schizophrenia, bipolar mania, and/or bipolar depression). The method includes orally administering to the subject an oral liquid suspension described herein.
    Type: Grant
    Filed: June 29, 2021
    Date of Patent: November 14, 2023
    Inventors: Paul Sudhakar, Scott Boyer
  • Topiramate oral liquid suspension and use thereof
    Patent number: 11759421
    Abstract: Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
    Type: Grant
    Filed: December 10, 2021
    Date of Patent: September 19, 2023
    Inventors: Paul Sudhakar, Scott Boyer
  • LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20230190759
    Abstract: The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
    Type: Application
    Filed: February 16, 2023
    Publication date: June 22, 2023
    Inventors: Paul Sudhakar, Scott Boyer
  • Lamotrigine oral liquid suspension and use thereof
    Patent number: 11612566
    Abstract: The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: March 28, 2023
    Inventors: Paul Sudhakar, Scott Boyer
  • Lamotrigine oral liquid suspension and use thereof
    Patent number: 11596634
    Abstract: The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: March 7, 2023
    Inventors: Paul Sudhakar, Scott Boyer
  • TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20220096377
    Abstract: Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 31, 2022
    Inventors: Paul Sudhakar, Scott Boyer
  • TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20220096378
    Abstract: Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
    Type: Application
    Filed: December 10, 2021
    Publication date: March 31, 2022
    Inventors: Paul Sudhakar, Scott Boyer
  • Topiramate oral liquid suspension and use thereof
    Patent number: 11197823
    Abstract: Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
    Type: Grant
    Filed: November 18, 2020
    Date of Patent: December 14, 2021
    Inventors: Paul Sudhakar, Scott Boyer
  • Topiramate oral liquid suspension and use thereof
    Patent number: 11197825
    Abstract: Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
    Type: Grant
    Filed: June 8, 2020
    Date of Patent: December 14, 2021
    Inventors: Paul Sudhakar, Scott Boyer
  • QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20210322440
    Abstract: The present invention provides for an oral liquid suspension that includes quetiapine or a pharmaceutically acceptable salt thereof. Also provided is a method for orally delivering quetiapine fumarate to a subject (e.g., for treating a mental disorder in a subject, such as schizophrenia, bipolar mania, and/or bipolar depression). The method includes orally administering to the subject an oral liquid suspension described herein.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Inventors: Paul Sudhakar, Scott Boyer
  • Quetiapine oral liquid suspension and use thereof
    Patent number: 11045481
    Abstract: The present invention provides for an oral liquid suspension that includes quetiapine or a pharmaceutically acceptable salt thereof. Also provided is a method for orally delivering quetiapine fumarate to a subject (e.g., for treating a mental disorder in a subject, such as schizophrenia, bipolar mania, and/or bipolar depression). The method includes orally administering to the subject an oral liquid suspension described herein.
    Type: Grant
    Filed: October 29, 2020
    Date of Patent: June 29, 2021
    Inventors: Paul Sudhakar, Scott Boyer
  • QUETIAPINE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20210121477
    Abstract: The present invention provides for an oral liquid suspension that includes quetiapine or a pharmaceutically acceptable salt thereof. Also provided is a method for orally delivering quetiapine fumarate to a subject (e.g., for treating a mental disorder in a subject, such as schizophrenia, bipolar mania, and/or bipolar depression). The method includes orally administering to the subject an oral liquid suspension described herein.
    Type: Application
    Filed: October 29, 2020
    Publication date: April 29, 2021
    Inventors: Paul Sudhakar, Scott Boyer
  • TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20210069107
    Abstract: Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Inventors: Paul Sudhakar, Scott Boyer
  • LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20210069109
    Abstract: The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
    Type: Application
    Filed: November 18, 2020
    Publication date: March 11, 2021
    Inventors: Paul Sudhakar, Scott Boyer
  • TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20200383911
    Abstract: Provided herein is an oral liquid suspension that includes topiramate, as well as methods of medical treatment that include orally administering the oral liquid suspension.
    Type: Application
    Filed: June 8, 2020
    Publication date: December 10, 2020
    Inventors: Paul Sudhakar, Scott Boyer
  • LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF
    Publication number: 20200375995
    Abstract: The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 3, 2020
    Inventors: Paul Sudhakar, Scott Boyer
  • COMPLEXES COMPRISING ZOLEDRONIC ACID AND CYCLODEXTRINS
    Publication number: 20090023683
    Abstract: The present invention relates to stable compositions comprising zoledronic acid, wherein zoledronic acid is complexed with a cyclodextrin, such as hydroxypropyl-?-cyclodextrin. The invention further relates to processes for making the compositions.
    Type: Application
    Filed: July 16, 2008
    Publication date: January 22, 2009
    Inventors: Chandrasekhar Kocherlakota, Paul Sudhakar Mogadati, Sarveswara Rao Mandavilli